Today: 8 February 2026
Subscribe
Browse Category

Mergers & Acquisitions News 26 December 2025 - 30 December 2025

DigitalBridge stock jumps as SoftBank agrees $4 billion buyout at $16 a share

DigitalBridge stock jumps as SoftBank agrees $4 billion buyout at $16 a share

DigitalBridge shares jumped nearly 10% premarket after SoftBank agreed to acquire the company for $16 per share in an all-cash deal valued at about $4 billion. The transaction is expected to close in the second half of 2026. DigitalBridge stock traded below the offer price, reflecting deal risk and the long timeline. Analysts reset ratings and targets to match the buyout price.
30 December 2025
···
DigitalBridge stock jumps nearly 10% on SoftBank’s $4 billion buyout offer — what investors watch next

DigitalBridge stock jumps nearly 10% on SoftBank’s $4 billion buyout offer — what investors watch next

DigitalBridge shares rose 9.7% to $15.27 after SoftBank agreed to acquire the company for $16 a share in cash, valuing it at about $4 billion including debt. The stock closed 4.6% below the offer price as traders watched for regulatory reviews and deal risk. About 86 million shares traded, well above average. The deal is expected to close in the second half of 2026.
30 December 2025
···
Constellation Energy stock today: CEG slips in thin year-end trade as Calpine deal stays in focus

Constellation Energy stock today: CEG slips in thin year-end trade as Calpine deal stays in focus

Constellation Energy shares fell 0.6% to $358.33 Monday as U.S. stocks slipped in thin holiday trading. The company’s pending Calpine acquisition advanced, with a key financing deadline extended to Jan. 12. Nuclear license renewals for Clinton and Dresden plants were approved. Utilities edged higher; the S&P 500 retreated from record highs.
30 December 2025
·······
JNJ stock today: J&J closes $3.05B Halda cancer deal, flags EPS hit — what’s next

JNJ stock today: J&J closes $3.05B Halda cancer deal, flags EPS hit — what’s next

Johnson & Johnson closed its $3.05 billion cash acquisition of Halda Therapeutics, a cancer drug developer, on Monday. The company said it expects about $0.20 in adjusted EPS dilution, split between the fourth quarter and 2026. JNJ shares ended down 0.02% at $207.56. Investors await the Jan. 21 earnings call for 2026 guidance.
30 December 2025
····
Philip Morris stock ticks up on Swedish Match plan filing as U.S. market softens

Philip Morris stock ticks up on Swedish Match plan filing as U.S. market softens

Philip Morris International shares rose 0.3% to $161.52 midday Monday after the company filed to register 500,000 shares for a Swedish Match North America employee profit-sharing plan. The filing, made on Form S-8, does not raise cash and relates to a program assumed in the 2022 Swedish Match acquisition. Other tobacco stocks were mixed. The broader market traded lower, with the S&P 500 ETF down 0.5%.
29 December 2025
··
WBD stock hovers near takeover price as Jan. 21 tender deadline nears

WBD stock hovers near takeover price as Jan. 21 tender deadline nears

Warner Bros Discovery shares rose 0.2% to $28.86 midday Monday, trading near levels implied by rival takeover bids. Paramount’s $30-per-share cash offer, backed by a $40.4 billion guarantee from Larry Ellison, faces a Jan. 21 deadline. Warner’s board has not changed its recommendation favoring a Netflix merger. The stock traded between $28.71 and $29.10 during the session.
29 December 2025
·····
Warner Bros Discovery stock stuck between Netflix deal value and Paramount’s $30 bid as Jan. 21 deadline nears

Warner Bros Discovery stock stuck between Netflix deal value and Paramount’s $30 bid as Jan. 21 deadline nears

Warner Bros. Discovery shares closed down 1.4% at $28.80, between Netflix’s $27.75-per-share deal value and Paramount’s $30 cash bid. Paramount extended its amended $30 tender offer to Jan. 21, 2026, and said Larry Ellison would guarantee $40.4 billion of financing. WBD’s board is reviewing the new offer but has not changed its support for the Netflix deal.
29 December 2025
·····
BP cashes in on Castrol: $10.1 billion Stonepeak deal sets up Castrol India share offer

BP cashes in on Castrol: $10.1 billion Stonepeak deal sets up Castrol India share offer

Stonepeak will buy 65% of BP’s Castrol lubricants business, valuing it at $10.1 billion. BP expects about $6 billion in net proceeds and will keep a 35% stake through a joint venture. Stonepeak and CPP Investments plan a mandatory open offer for Castrol India at 194.04 rupees per share after the global deal closes. The transaction is expected to complete by the end of 2026.
29 December 2025
··
ServiceNow (NOW) Stock Weekend Update: What Wall Street Is Watching After the $7.75B Armis Deal, CEO Contract Extension, and Fresh Analyst Targets

ServiceNow (NOW) Stock Weekend Update: What Wall Street Is Watching After the $7.75B Armis Deal, CEO Contract Extension, and Fresh Analyst Targets

ServiceNow closed Friday at $153.89, up 0.85%, with 5 million shares traded. The stock has hovered in the mid-$150s since announcing its $7.75 billion Armis acquisition. Bloomberg reports ServiceNow spent at least $12 billion on deals in 2025. TD Cowen cut its price target to $230, citing M&A risks.
28 December 2025
··
ServiceNow (NOW) Stock Today: Analyst Price Targets, Armis Deal Digest, and What to Watch Before Monday’s Open

ServiceNow (NOW) Stock Today: Analyst Price Targets, Armis Deal Digest, and What to Watch Before Monday’s Open

ServiceNow shares closed at $153.89 on Dec. 26, up 0.85%, as Wall Street weighed its planned $7.75 billion cash acquisition of Armis. TD Cowen cut its price target on ServiceNow to $230 from $250, citing integration and financing risks. The deal is expected to close in the second half of 2026, pending approvals. U.S. equity markets were subdued Friday after a five-session run-up.
27 December 2025
··
Warner Bros. Discovery Stock (WBD) Weekend Update: Deal-Arbitrage Tension Builds Ahead of Monday’s Open

Warner Bros. Discovery Stock (WBD) Weekend Update: Deal-Arbitrage Tension Builds Ahead of Monday’s Open

Warner Bros. Discovery shares closed at $28.80 Friday, down 1.4%, as investors weighed a $27.75-per-share Netflix takeover deal against a $30 all-cash offer from Paramount Skydance, now backed by a $40.4 billion personal guarantee from Larry Ellison. Paramount extended its tender offer to Jan. 21, 2026, with 397,252 shares tendered as of Dec. 19.
27 December 2025
····
Global M&A Boom in 2025: Dealmaking Hits $4.5 Trillion as Trump Antitrust Shift Fuels Megadeals and the Warner Bros Bidding War

Global M&A Boom in 2025: Dealmaking Hits $4.5 Trillion as Trump Antitrust Shift Fuels Megadeals and the Warner Bros Bidding War

Global mergers and acquisitions reached nearly $4.8 trillion in 2025, the second-highest total on record, according to Dealogic. December alone saw $463.6 billion in announced deals. The surge was driven by a wave of megadeals and shifting U.S. antitrust policy under President Trump’s second term. Dealmakers say boards are prioritizing fewer, larger transactions.
27 December 2025
·
Merck Stock (MRK) News and Forecasts: FDA Fast-Track Vouchers, TrumpRx Pricing Deal, and Cidara Acquisition in Focus Ahead of the Next Market Session

Merck Stock (MRK) News and Forecasts: FDA Fast-Track Vouchers, TrumpRx Pricing Deal, and Cidara Acquisition in Focus Ahead of the Next Market Session

U.S. stock markets are closed for the weekend as of 2:34 a.m. ET Saturday. Merck last traded near $106.78, up 0.33%. The company is in focus after joining TrumpRx-linked drug pricing deals and announcing 70% discounts on diabetes drugs for U.S. consumers. Trading volume remains thin following a flat Friday session.
27 December 2025
···
WBD Stock Update: Warner Bros. Discovery Shares Hover Near $29 as Netflix Deal, Paramount Bid, and Antitrust Risk Shape the Trade

WBD Stock Update: Warner Bros. Discovery Shares Hover Near $29 as Netflix Deal, Paramount Bid, and Antitrust Risk Shape the Trade

Warner Bros. Discovery closed Friday at $28.80, above the $27.75-per-share value in its $72 billion studios and streaming sale to Netflix. Paramount Skydance is pursuing a hostile $30-per-share takeover bid, backed by Larry Ellison, which WBD’s board rejected. The deals face regulatory review and depend on WBD’s planned corporate split. Trading remains volatile as investors weigh competing offers and deal risks.
27 December 2025
····
Netflix Stock (NFLX) Today: Shares Tick Higher as Wall Street Weighs Warner Bros. Deal Financing, Regulatory Risk, and Q4 Earnings Ahead

Netflix Stock (NFLX) Today: Shares Tick Higher as Wall Street Weighs Warner Bros. Deal Financing, Regulatory Risk, and Q4 Earnings Ahead

Netflix shares traded at $94.22, up 0.6% Friday afternoon, as investors focused on its $82.7 billion deal to acquire Warner Bros. Discovery assets. The proposed transaction would give Warner shareholders $23.25 in cash and about $4.50 in Netflix stock per share, with the stock portion subject to a collar. Closing is expected in 12–18 months, pending Warner’s planned spinoff of its Global Networks unit.
26 December 2025
···
Abivax (ABVX) Stock in Focus: Eli Lilly Takeover Chatter, Obefazimod Phase 3 Momentum, and What to Watch Before the Next U.S. Session

Abivax (ABVX) Stock in Focus: Eli Lilly Takeover Chatter, Obefazimod Phase 3 Momentum, and What to Watch Before the Next U.S. Session

Abivax (NASDAQ: ABVX) rose about 5.3% to $145.31 in premarket trading Friday, with U.S. markets the main venue as Euronext remained closed for St. Stephen’s Day. The stock has surged in December amid Eli Lilly takeover rumors, recent inclusion in the Nasdaq Biotechnology Index, and ongoing interest in its ulcerative colitis drug obefazimod.
26 December 2025
···
1 2 3 … 20

Stock Market Today

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 08.02.2026

8 February 2026
LIVEMarkets rolling coverageStarted: February 8, 2026, 12:00 AM ESTUpdated: February 8, 2026, 12:53 AM EST Australian Shares Set for Volatile Earnings Season Amid Market Sensitivity February 8, 2026, 12:49 AM EST. **Australian stock markets** face heightened volatility as earnings season kicks off with little room for error. Analysts warn that even a **1% earnings miss** could trigger sharp price swings, stripping away previous insulation from market shocks. This turbulence reflects the removal of 'shock absorbers' in share prices, signaling an unpredictable three weeks ahead for investors. Anthony Macdonald, business journalist and Chanticleer columnist, forecasts significant fluctuations likely exceeding historical norms.
Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026
Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.
Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026
Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026
MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.
Go toTop